UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 277

Sortiert nach

Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands

Kidney international, 2007-01, Vol.71 (2), p.153-158

2007

Volltextzugriff (PDF)

Prospective economic evaluation of the costs for medications and nutraceuticals in knee osteoarthritis

Osteoarthritis and cartilage, 2016-04, Vol.24, p.S349-S350

2016

Volltextzugriff (PDF)

Economic burden of medications and nutraceuticals in knee osteoarthritis

Osteoarthritis and cartilage, 2015-04, Vol.23, p.A198-A199

2015

Volltextzugriff (PDF)

AN OVERVIEW OF STATISTICAL METHODS FOR META-ANALYSES COMBINING INDIVIDUAL PARTICIPANT DATA AND AGGREGATE DATA

Value in health, 2016-05, Vol.19 (3), p.A91-A91

2016

Volltextzugriff (PDF)

Intra-articular corticosteroids may be a cost-effective strategy for short-term management of knee osteoarthritis

Osteoarthritis and cartilage, 2015-04, Vol.23, p.A392-A394

2015

Volltextzugriff (PDF)

Guidance For The Conduct And Reporting Of Modeling And Simulation In The Context Of Health Technology Assessment

Value in health, 2015-05, Vol.18 (3), p.A7-A7

2015

Volltextzugriff (PDF)

Differential response of placebo treatments in osteoarthritis trials: a systematic review and network meta-analysis

Osteoarthritis and cartilage, 2014-04, Vol.22, p.S24-S25

2014

Volltextzugriff (PDF)

The Value of Risk-Stratified Information in the National Lung Cancer Screening Trial

Value in health, 2014-11, Vol.17 (7), p.A324-A325

2014

Volltextzugriff (PDF)

[522] COST-EFFECTIVENESS OF TELBIVUDINE VERSUS LAMIVUDINE FOR CHRONIC HEPATITIS B

Journal of hepatology, 2007, Vol.46, p.S199-S199

2007

Volltextzugriff (PDF)

PIN24 Potential Costs Associated with New Direct Acting Antiviral (DAAs) Therapy for Untreated Chronic Hepatitis C Genotype 1 Infection in the Veterans Health Administration

Value in health, 2011, Vol.14 (7), p.A269-A270

2011

Volltextzugriff (PDF)

Tai Chi versus physical therapy for knee osteoarthritis: a cost-effectiveness analysis

Osteoarthritis and cartilage, 2018-04, Vol.26, p.S312-S313

2018

Volltextzugriff (PDF)

Predicting dysphagia onset in patients with ALS: the ALS dysphagia risk score

Amyotrophic lateral sclerosis and frontotemporal degeneration, 2022-04, Vol.23 (3-4), p.271-278

2022

Volltextzugriff (PDF)

PRM112 - AN OVERVIEW OF STATISTICAL METHODS FOR META-ANALYSES COMBINING INDIVIDUAL PARTICIPANT DATA AND AGGREGATE DATA

Value in health, 2016-05, Vol.19 (3), p.A91-A91

2016

Volltextzugriff (PDF)

Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States

Journal of viral hepatitis, 2007-02, Vol.14 (2), p.107-115

2007

Volltextzugriff (PDF)

CP4 - Guidance For The Conduct And Reporting Of Modeling And Simulation In The Context Of Health Technology Assessment

Value in health, 2015-05, Vol.18 (3), p.A7-A7

2015

Volltextzugriff (PDF)

DI2 - The Value of Risk-Stratified Information in the National Lung Cancer Screening Trial

Value in health, 2014-11, Vol.17 (7), p.A324-A325

2014

Volltextzugriff (PDF)

Cost effectiveness of peginterferon α-2b plus ribavirin versus interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C

Gut, 2003-03, Vol.52 (3), p.425-432

2003

Volltextzugriff (PDF)

Arch Intern Med: Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials

Alternative medicine review, 2009-06, Vol.14 (2), p.189

2009

Volltextzugriff (PDF)

O.037 Prediction of HCV-related morbidity and mortality burden in France using the back-calculation method

Journal of clinical virology, 2006, Vol.36, p.S11-S12

2006

Volltextzugriff (PDF)

515 Cost-effectiveness of peginterferon plus ribavirin in a real-world population of patients with chronic hepatitis C and associated comorbidities

Journal of hepatology, 2004, Vol.40, p.152-152

2004

Volltextzugriff (PDF)

Biophysical Characterization of an Integrin-Targeted Lipopolyplex Gene Delivery Vector

Biochemistry (Easton), 2006-02

2006

Volltextzugriff (PDF)

Evaluating rapid virological response reduces ribavirin and peginterferon alfa-2B treatment costs for chronic hepatitis C in the United Kingdom

Journal of hepatology, 2003-04, Vol.38, p.181-182

2003

Volltextzugriff (PDF)

Is peginterferon alfa-2B plus ribavirin cost-effective for treating chronic hepatitis C in the United Kingdom?

Journal of hepatology, 2003-04, Vol.38, p.181-181

2003

Volltextzugriff (PDF)

The influence of analytic time horizon and treatment management algorithms on the cost of peginterferon alfa-2b plus ribavirin therapy for chronic hepatitis C

Journal of hepatology, 2003-04, Vol.38, p.173-173

2003

Volltextzugriff (PDF)

Validating a Markov model of treatment for hepatitis C virus-related hepatocellular carcinoma

Methods of information in medicine, 2008-01, Vol.47 (6), p.529

2008

Volltextzugriff (PDF)

1 – 25 von 277

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(216)
Mit Volltextzugriff
(257)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(155)
Physical Sciences
(69)
Life Sciences & Biomedicine
(63)
Technology
(63)
Physics
(61)
Humans
(38)
Materials Science
(34)
Exact Sciences And Technology
(28)
Physics, Applied
(26)
Biological And Medical Sciences
(23)
Male
(23)
Materials Science, Multidisciplinary
(23)
Engineering
(21)
Physics, Condensed Matter
(21)
Female
(20)
Animals
(17)
Adult
(16)
Physics, Nuclear
(16)
Medical Sciences
(15)
Condensed Matter: Electronic Structure, Electrical, Magnetic, And Optical Properties
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands

Prospective economic evaluation of the costs for medications and nutraceuticals in knee osteoarthritis

Economic burden of medications and nutraceuticals in knee osteoarthritis

AN OVERVIEW OF STATISTICAL METHODS FOR META-ANALYSES COMBINING INDIVIDUAL PARTICIPANT DATA AND AGGREGATE DATA

Intra-articular corticosteroids may be a cost-effective strategy for short-term management of knee osteoarthritis

Guidance For The Conduct And Reporting Of Modeling And Simulation In The Context Of Health Technology Assessment

Differential response of placebo treatments in osteoarthritis trials: a systematic review and network meta-analysis

The Value of Risk-Stratified Information in the National Lung Cancer Screening Trial

[522] COST-EFFECTIVENESS OF TELBIVUDINE VERSUS LAMIVUDINE FOR CHRONIC HEPATITIS B

PIN24 Potential Costs Associated with New Direct Acting Antiviral (DAAs) Therapy for Untreated Chronic Hepatitis C Genotype 1 Infection in the Veterans Health Administration

Tai Chi versus physical therapy for knee osteoarthritis: a cost-effectiveness analysis

Predicting dysphagia onset in patients with ALS: the ALS dysphagia risk score

PRM112 - AN OVERVIEW OF STATISTICAL METHODS FOR META-ANALYSES COMBINING INDIVIDUAL PARTICIPANT DATA AND AGGREGATE DATA

Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States

CP4 - Guidance For The Conduct And Reporting Of Modeling And Simulation In The Context Of Health Technology Assessment

DI2 - The Value of Risk-Stratified Information in the National Lung Cancer Screening Trial

Cost effectiveness of peginterferon α-2b plus ribavirin versus interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C

Arch Intern Med: Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials

O.037 Prediction of HCV-related morbidity and mortality burden in France using the back-calculation method

515 Cost-effectiveness of peginterferon plus ribavirin in a real-world population of patients with chronic hepatitis C and associated comorbidities

Biophysical Characterization of an Integrin-Targeted Lipopolyplex Gene Delivery Vector

Evaluating rapid virological response reduces ribavirin and peginterferon alfa-2B treatment costs for chronic hepatitis C in the United Kingdom

Is peginterferon alfa-2B plus ribavirin cost-effective for treating chronic hepatitis C in the United Kingdom?

The influence of analytic time horizon and treatment management algorithms on the cost of peginterferon alfa-2b plus ribavirin therapy for chronic hepatitis C

Validating a Markov model of treatment for hepatitis C virus-related hepatocellular carcinoma

Suchergebnisse filtern